CD8 + T cells are a crucial part of the adaptive immune system, responsible for combating intracellular pathogens and tumor cells. The initial activation of T cells involves the formation of highly dynamic Ca 2+ microdomains. Recently, purinergic signaling was shown to be involved in the formation of the initial Ca 2+ microdomains in CD4 + T cells. In this study, the role of purinergic cation channels, particularly P2X4 and P2X7, in CD8 + T cell signaling from initial events to downstream responses was investigated, focusing on various aspects of T cell activation, including Ca 2+ microdomains, global Ca 2+ responses, NFAT-1 translocation, cytokine expression, and proliferation. While Ca 2+ microdomain formation was significantly reduced in the first milliseconds to seconds in CD8 + T cells lacking P2X4 and P2X7 channels, global Ca 2+ responses over minutes were comparable between wild-type (WT) and knockout cells. However, the onset velocity was reduced in P2X4-deficient cells, and P2X4, as well as P2X7-deficient cells, exhibited a delayed response to reach a certain level of free cytosolic Ca 2+ concentration ([Ca 2+ ] i ). NFAT-1 translocation, a crucial transcription factor in T cell activation, was also impaired in CD8 + T cells lacking P2X4 and P2X7. In addition, the expression of IFN-γ, a major pro-inflammatory cytokine produced by activated CD8 + T cells, and Nur77, a negative regulator of T cell activation, was significantly reduced 18h post-stimulation in the knockout cells. In line, the proliferation of T cells after 3 days was also impaired in the absence of P2X4 and P2X7 channels. In summary, the study demonstrates that purinergic signaling through P2X4 and P2X7 enhances initial Ca 2+ events during CD8 + T cell activation and plays a crucial role in regulating downstream responses, including NFAT-1 translocation, cytokine expression, and proliferation on multiple timescales. These findings suggest that targeting purinergic signaling pathways may offer potential therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Brock et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: